Modulation of inducible nitric oxide synthase induction by prostaglandin E2 in macrophages: Distinct susceptibility in murine J774 and RAW 264.7 macrophages

Prostaglandins and Other Lipid Mediators

Volumn 58, Issue 2-4, 1999, Pages 87-101

  Lina, Wan Wan ^a   Chen, Bing Chang ^a   Hsu, Ya Wen ^a   Lee, Chii Ming ^a   Shyue, Song Kun ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b ACADEMIA SINICA   (Taiwan)

Author keywords

cAMP; LPS; Murine macrophage; Nitric oxide; Prostaglandin E2

Indexed keywords

CYCLIC AMP; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN E2;

ANIMAL CELL; ARTICLE; CELL CULTURE; ENZYME ACTIVITY; ENZYME INDUCTION; IMMUNOBLOTTING; MACROPHAGE; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION;

ANIMALS; BUCLADESINE; CELL LINE; CYCLIC AMP; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; INDOMETHACIN; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; SALICYLIC ACIDS;

EID: 0345466464     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(99)00023-4     Document Type: Article

References (45)

1. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide physiology, pathophysiology and pharmacology . Pharmacol Rev. 43:1991;109-142.
2. Nathan C., Hibbs J.B. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol. 3:1991;65-70.
3. Radi R., Beckman J.S., Bush K.M., Freeman B.A. Peroxynitrite oxidation of sulfhydryls the cytotoxic potential of superoxide and nitric oxide . J Biol Chem. 266:1991;4244-4250.
4. Phipps R.P., Stein S.H., Roper R.L. A new view of prostaglandin E regulation of the immune response. Immunol Today. 12:1991;349-352.
5. Mebmer U.K., Lapetina E.G., Brune B. Nitric oxide-induced apoptosis in RAW 264.7 macrophages is antagonized by protein kinase C- and protein kinase A-activating compounds. Mol Pharmacol. 47:1995;757-765.
6. Von Knethen A., Brune B. Cyclooxygenase-2 an essential regulator of NO-mediated apoptosis . FASEB J. 11:1997;887-895.
7. 2 endogenous mediators of interleukin-1 production. J Immunol. 136:1986;186-192.
8. 2. J Exp Med. 180:1994;2365-2370.
9. 2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2R alpha gene expression at multiple levels. J Immunol. 148:1992;2845-2852.
10. Kambayashi T., Jacob C.O., Zhou D., Mazurek N., Fong M., Strassmann G. Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in subsequent inhibition of TNF-α and IL-6 release by endotoxin-stimulated macrophages. J Immunol. 155:1995;4909-4916.
11. Platzer C., Meisel C., Vogt K., Platzer M., Volk H.D. Up-regulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs. Int Immunol. 7:1995;517-523.
12. 1 stimulates interleukin-6 secretion via protein kinase A in osteoblast-like cells. Cell Signal. 9:1997;105-108.
13. Stratman N.C., Carter D.B., Sethy V.H. Ibuprofen effect on inducible nitric oxide synthase . Brain Res Mol Brain Res. 50:1997;107-112.
14. 2 production in response to lipopolysaccharide in the macrophage cell line J774A.1. Eur J Immunol. 27:1997;742-749.
15. Astin M., Stjemschantz J., Selen G. Role of nitric oxide in PGF2α-induced ocular hyperemia. Exp Eye Res. 59:1994;401-407.
16. Koide M., Kawahara Y., Nakayama I., Tsuda T., Yokoyama M. Cyclic AMP-elevating agents induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells. J Biol Chem. 268:1993;24959-24966.
17. 2 on the induction of nitric oxide and prostaglandin-forming pathways in cultured rat mesangial cells. Biochem J. 313:1996;617-623.
18. 2 of cytokine elicited nitric oxide synthesis in rat liver macrophages. J Biol Chem. 373:1992;897-902.
19. Benbernou N., Esnault S., Shin H.C.K., Fekkar H., Guenounou M. Differential regulation of IFN-γ, IL-10 and inducible nitric oxide synthase in human T cells by cyclic AMP-dependent signal transduction pathway. Immunology. 91:1997;361-368.
20. Barker J.E., Anderson J., Treasure T., Piper P.J. Effects of prostaglandins on stimulated release of nitric oxide by angiotensin II from human saphenous vein. Br J Pharmacol. 112:(suppl.):1994;446P.
21. 2 negatively modulates induction of nitric oxide synthase by interleukin-1 . Proc Natl Acad Sci USA. 91:1994;12168-12172.
22. 2 biosynthesis stimulated by interleukin-1β J Biol Chem. 272:1997;8083-8089.
23. Raddassi K., Petit J.F., Lemaire G. LPS-induced activation of primed murine peritoneal macrophages is modulated by prostaglandins and cyclic nucleotides. Cell Immunol. 149:1993;50-64.
24. Marotta P., Sautebin L., DiRosa M. Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774. Br J Pharmacol. 107:1992;640-641.
25. 2 and other cyclic AMP stimulants in J774 macrophages. Biochem Pharmacol. 53:1997;493-500.
26. Hirokawa K., O'Shaughnessy K., Moore K., Ramrakha P., Wilkins M.R. Induction of nitric oxide synthase in cultured vascular smooth muscle cells the role of cyclic AMP . Br J Pharmacol. 112:1994;396-402.
27. Ima T., Hirata Y., Kanno K., Marumo F. Induction of nitric oxide synthase by cyclic AMP in rat vascular smooth muscle cells. J Clin Invest. 93:1994;543-549.
28. Sowa G., Przewlocki R. cAMP analogues and cholera toxin stimulate the accumulation of nitrite in rat peritoneal macrophage cultures. Eur J Pharmacol. 266:1994;125-129.
29. Mustafa S.B., Olson M.S. Expression of nitric-oxide synthase in rat Kupffer cells is regulated by cAMP. J Biol Chem. 273:1998;5073-5080.
30. Hasko G., Nemeth Z.H., Szabo C., Zsilla G., Salzman A.L., Vizi E.S. Isoproterenol inhibits IL-10, TNF-α and nitric oxide production in RAW 264.7 macrophages. Brain Res Bulletin. 45:1998;183-187.
31. 2 in RAW 264.7 macrophages. Br J Pharmacol. 119:1996;261-268.
32. Lin W.W., Chen B.C. Involvement of protein kinase C in the UTP-mediated potentiation of cyclic AMP accumulation in mouse J774 macrophages. Br J Pharmacol. 121:1997;1749-1757.
33. 2 receptors on U937 human monocytic cells. Immunology. 896:1995;620-628.
34. Arakawa T., Laneuville O., Miller C.A., Lakkides K.M., Wingerd B.A., DeWitt D.L., Smith W.L. Prostanoid receptors of murine NIH 3T3 and RAW 264.7 cells. J Biol Chem. 271:1996;29569-29575.
35. 2 receptor subtype 4 mRNA in human mononuclear Jurkat and KM-3 cells and coexpression of subtype 4 and 2 mRNA in U-937 cells. FEBS Lett. 394:1996;39-43.
36. 2 in a murine model of inflammation possible role of cyclooxygenase-2 . Proc Natl Acad Sci USA. 93:1996;4885-4890.
37. 2. Distinct roles of cyclooxygenase-1 and -2. J Biol Chem. 272:1997;25693-25699.
38. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA. 90:1993;7240-7244.
39. Swierkosz T.A., Mitchell J.A., Warner T.D., Botting R.M., Vane J.R. Co-induction of nitric oxide synthase and cyclooxygenase interactions between nitric oxide and prostanoids . Br J Pharmacol. 114:1995;1335-1342.
40. 2α receptors and receptor-coupled second messengers by cyclooxygenase inhibition in newborn pigs. J Pharmacol Exp Ther. 272:1995;15-19.
41. Rice M.G., Mcroe J.R., Storm D.R., Robertson R.P. Up-regulation of hepatic prostaglandin E receptors in vivo induced by prostaglandin synthesis inhibitors. Am J Physiol. 241:1981;E291-E297.
42. 2 inhibition of PWM-stimulated lymphocytes from neoplastic patients. Clin Immuno Immunopathol. 87:1998;115-123.
43. Eberhardt W., Kunz D., Hummel R., Pfeilschifter J. Molecular cloning of the rat inducible nitric oxide synthase gene promoter. Biochem Biophys Res Commun. 223:1996;752-756.
44. Coleman R.A., Smith W.L., Nurumiya S. International union of pharmacology classification of prostanoid receptors properties, distribution, and structure of the receptors and their subtypes . Pharmacol Rev. 46:1994;205-229.
45. Negishi M., Sugimoto Y., Ichidawa A. Molecular mechanisms of diverse actions of prostanoid receptors. Biochim Biophys Acta. 1259:1995;109-119.